Medical News

RSS

Study assesses microbiome of male genital mucosa

A new study in the journal Microorganisms aimed to identify and analyze studies on the composition of the microbial community on different parts of the healthy and diseased male genital mucosa.

4 Jan 2023

Maternal primary language associated with breastfeeding continuation during NICU hospitalization

Very-low-birthweight (VLBW) infants are at substantially higher risk for chronic health problems and neurodevelopmental disabilities compared with full term infants.

4 Jan 2023

Mediterranean diet may benefit health in part by incorporating moderate wine consumption

Many public health warnings have been issued against alcohol consumption, even in small quantities, though the evidence for such strict limits is controversial. The current study, published in the MDPI journal Nutrients, is a narrative review focused on clearing up some of the confusion associated with alcoholic drinks.

4 Jan 2023

Early intervention key to managing diabetes, cardiorenal, and metabolic diseases

A panel of US-based experts in cardiology, nephrology, endocrinology, and primary care has prepared specific recommendations for early identification and intervention in obesity, diabetes, and other cardiorenal and metabolic diseases. A detailed report on recommended strategies has been published in the Journal of Diabetes and its Complications.

4 Jan 2023

UH researchers work towards a mobile intervention for Black American smokers with HIV

HIV remains a critical global public health issue and a significant threat to global health security after having claimed more than 40 million lives, according to the World Health Organization.

4 Jan 2023

Incurable liver disease could be reversed with a single drug

Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the liver, could be reversed with a single drug.

4 Jan 2023

Study shows the prevalence of low-value prostate cancer screening in primary care clinics

Prostate cancer is the second-leading cause of cancer death in men with more than 34,000 deaths in the U.S. each year, according to the American Cancer Society.

4 Jan 2023

Study shows the potential of a game-changing drug to treat upper urinary tract urothelial cancers

A team from 15 U.S. medical centers led by UT Southwestern Simmons Cancer Center researchers has performed the first analysis of a potentially game-changing drug to treat upper urinary tract urothelial cancers.

4 Jan 2023

New dual-action, cancer-killing vaccine tested in an advanced mouse model of glioblastoma

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, investigators have developed a new cell therapy approach to eliminate established tumors and induce long-term immunity, training the immune system so that it can prevent cancer from recurring.

4 Jan 2023

Researchers discover novel candidate drug targets for advanced non-alcoholic fatty liver disease

Using the latest technologies - including both single-nuclear sequencing of mice and human liver tissue and advanced 3D glass imaging of mice to characterize key scar-producing liver cells - researchers have uncovered novel candidate drug targets for non-alcoholic fatty liver disease (NAFLD).

4 Jan 2023

Study demonstrates safety and efficacy of a three-dose whole-parasite vaccine against malaria

A three-dose regimen of a whole-parasite vaccine against malaria – called Plasmodium falciparum sporozoite (PfSPZ) vaccine – demonstrated safety and efficacy when tested in adults living in Burkina Faso, West Africa, which has endemic malaria.

4 Jan 2023

Distinct genomic patterns of malignant peripheral nerve sheath tumors may help with early diagnosis

Neurofibromatosis type 1 (NF1) is a common genetic condition, affecting 1 in 3000 individuals, and people with NF1 are at greater risk of developing a rare, aggressive form of cancer.

4 Jan 2023

Research offers a cost-effectiveness analysis of anticoagulant drugs for cancer-associated thrombosis

Newly published research out of the University of Cincinnati and the University of California-Davis shows that direct oral anticoagulant (DOAC) drugs are more effective and are more cost-effective than low molecular weight heparin for treating cancer-associated thrombosis.

4 Jan 2023

How do parents respond to messages that discourage soda, encourage water or both?

A recent study found that messaging campaigns discouraging the consumption of unhealthy beverages were more promising than those promoting healthy drinks among parents in the United States.

4 Jan 2023

Is platelet-rich plasma therapy beneficial in treating chronic respiratory disease?

Researchers conducted a literature review to determine whether platelet-rich plasma therapy could help slow disease progression through lung regeneration in patients with chronic respiratory disease.

4 Jan 2023

RQM+ Launches Clinical Trial Services

RQM+ today announced the launch of its clinical trial services division to complete its full complement of MedTech contract research organization (CRO) services.

From RQM+ 4 Jan 2023

New insights into the bioavailability and hepatoxicity risk of neonicotinoids

Researchers quantified the residues of eight neonicotinoids in human bile samples to understand the association between internal neonicotinoid exposure and hepatotoxic outcomes.

4 Jan 2023

The relationship between metabolic disease and alternations in lipid homeostasis

Researchers assessed the function of lipids in metabolic diseases.

4 Jan 2023

The relationship between medical and recreational cannabis laws and the state-level prevalence of pediatric asthma in the US

Researchers evaluated the impact of cannabis legalization on pediatric asthma in the United States (US).

4 Jan 2023

Dietary supplement can reverse the signs of heart disease in a subset of patients

When we were little, our parents told us to take our vitamins so we could grow big and strong. Now, researchers from Japan find that one particular supplement may even fix a broken heart.

4 Jan 2023

Medical News

Study assesses microbiome of male genital mucosa

Maternal primary language associated with breastfeeding continuation during NICU hospitalization

Mediterranean diet may benefit health in part by incorporating moderate wine consumption

Early intervention key to managing diabetes, cardiorenal, and metabolic diseases

UH researchers work towards a mobile intervention for Black American smokers with HIV

Incurable liver disease could be reversed with a single drug

Study shows the prevalence of low-value prostate cancer screening in primary care clinics

Study shows the potential of a game-changing drug to treat upper urinary tract urothelial cancers

New dual-action, cancer-killing vaccine tested in an advanced mouse model of glioblastoma

Researchers discover novel candidate drug targets for advanced non-alcoholic fatty liver disease

Study demonstrates safety and efficacy of a three-dose whole-parasite vaccine against malaria

Distinct genomic patterns of malignant peripheral nerve sheath tumors may help with early diagnosis

Research offers a cost-effectiveness analysis of anticoagulant drugs for cancer-associated thrombosis

How do parents respond to messages that discourage soda, encourage water or both?

Is platelet-rich plasma therapy beneficial in treating chronic respiratory disease?

RQM+ Launches Clinical Trial Services

New insights into the bioavailability and hepatoxicity risk of neonicotinoids

The relationship between metabolic disease and alternations in lipid homeostasis

The relationship between medical and recreational cannabis laws and the state-level prevalence of pediatric asthma in the US

Dietary supplement can reverse the signs of heart disease in a subset of patients

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News